Navigation Links
Biomet Hip Lawsuits Move Forward as Judge Designates Venues for Depositions in Federal Biomet Hip Replacement Litigation, Bernstein Liebhard LLP Reports
Date:6/13/2013

metal-on-metal hip implants" onclick="linkClick(this.href)">metal-on-metal hip implants are currently the subject of a U.S. Food & Drug Administration (FDA) safety review. In January 2013, the agency warned that metal debris shed from such devices could accumulate at dangerous levels in the tissue surrounding the hip implant, as well as the blood stream. According to the FDA, this could lead to pain, swelling, metallosis, premature failure of the hip, and possibly even systemic reactions in other parts of the body. The FDA has advised that patients with all-metal hips undergo blood testing for elevated metal ion levels if they show signs of a failing hip implant. The FDA has also proposed a new rule which would preclude metal-on-metal hips from the agency’s 510 (k) clearance process, which allowed devices like the Biomet M2a Magnum to come to market without first undergoing human clinical trials.*

Alleged victims of metal-on-metal hip implant failure associated with the Biomet M2a hip may be entitled to compensation for medical bills, lost wages, and pain and suffering. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Biomet Hip Replacement Claims: Bernstein Liebhard LLP Looks Ahead to Next Case Management Conference in Federal Litigation of Biomet Hip Lawsuits
2. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on Ongoing Biomet M2a Magnum Hip Replacement Studies
3. MinuteHound Announces Software Update Featuring Safe and Effective Biometric Recognition
4. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Developments in Federal Litigation for Biomet Hip Replacement Lawsuits
5. PharmaSmart® and Kinney Drugs Partner up to Unveil Newest Advancement in Pharmacy-Based Biometric Screening and Mobile Interoperability
6. Biomet Hip Lawsuit: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Biomet Hip Replacement Litigation
7. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Biomet Hip Litigation
8. MinuteHound Releases Time Clock Software Featuring Secure Biometric Technology for Business Applications
9. MinuteHound Annouces Top 5 Reasons Businesses Increasingly Switching To Biometrics
10. Law Firm Issues Biomet Hip Infographic Warning Consumers About the Dangers of Biomet Hip Implants
11. MinuteHound News: Top Three Ways To Save Money With Biometric Time and Attendance Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014) McMaster scientists have found that an ... of antibiotics. , Although dozens of antibiotics target ... a certain part of bacteria are created, and they ... , The discovery is important as there is growing ... cures for infections ineffective. The World Health Organization has ...
(Date:9/22/2014)... 2014 Quincy Bioscience, one of ... promotes National Self-Improvement Month this September. ... should have access to self-improvement resources, especially for ... demand for products that preserve health is growing ... For over six years, Quincy Bioscience has been ...
(Date:9/22/2014)... (HealthDay News) -- Scans of young children,s brains ... This finding could potentially allow doctors to identify ... on, preliminary research suggests. "Early identification and ... as well as most neurodevelopmental disorders," the study,s ... of child and adolescent psychiatry at University of ...
(Date:9/22/2014)... September 22, 2014 In a continued ... Jeep Dodge Ram is launching an awareness campaign inspired ... (#blindeggchallenge or #ffbBEC) aims to raise awareness and funds ... throwing an egg in the air and trying to ... others and if a nominee does not complete the ...
(Date:9/22/2014)... 22, 2014 The struggles that lie ... (LEP) patients has been well-documented—reportedly, language barriers between doctors ... to the emergency room and an increased likelihood for ... At Sanford Health, the largest medical facility in the ... LEP population necessitated the need for Video Remote ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will be conducting a ... 11:30 am Eastern Time. , , Event: ... Dan Starck, President and CEO, ... 11:30 am Eastern Time, Tuesday, February 3rd, ...
... success rate is much lower for those over 40 who want ... Women under 35 who undergo six cycles of in vitro fertilization ... new study found. , But for women over 40, the odds ... , "IVF is a mainstay of the treatment of infertility, and ...
... 14 ISP and IT partner Spiderhost ... initiative by Get Healthy Florida to get ... most comprehensive community-wide health project to date: a year-long ... awareness of blood pressure and cardiovascular risk.The project challenges ...
... 14 Congressman Chaka Fattah (D-PA) issues the ... the SCHIP children,s insurance program by a bipartisan vote of ... , "The effort to bring change to Washington ... children took a major stride today. I have joined with ...
... RIVER EDGE, N.J., Jan. 14 Nephros, Inc. ... company developing and marketing filtration products for therapeutic ... that it has received notice from the NYSE ... or "AMEX" or the "Exchange"), regarding AMEX,s intention ...
... still share outcome disparities in treatment of liver disease, study ... treatment for hepatitis C does not appear to help Hispanic ... non-Hispanic whites, a new study suggests. , This is second ... not to respond well to the therapy, consisting of pegylated ...
Cached Medicine News:Health News:CorVel Corporation Announces Earnings Release Webcast 2Health News:IVF Treatments Often Work for Women Under 35 2Health News:IVF Treatments Often Work for Women Under 35 3Health News:Spiderhost's Custom Programming Helps Central Floridians Get Healthy 2Health News:Nephros Receives Notice of Intention to Delist from AMEX 2Health News:Nephros Receives Notice of Intention to Delist from AMEX 3Health News:Nephros Receives Notice of Intention to Delist from AMEX 4Health News:Hispanics Respond Poorly to Standard Hepatitis C Therapy 2
(Date:9/22/2014)... , Sept. 22, 2014  AbbVie (NYSE: ... several clinical studies evaluating potential new medicines in ... the upcoming 2014 European Society of Medical Oncology ... Madrid, Spain . Data being presented include ... safety and efficacy of veliparib (ABT-888), a poly ...
(Date:9/22/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... overview and update at the NewsMakers in the Biotech ... a.m. Eastern Time (8:30 a.m. Pacific Time), at the ... . A live audio webcast of ... section of Arena,s website at www.arenapharm.com . A ...
(Date:9/22/2014)... , September 22, 2014 ... "Cell Line Development Market by Product (Equipment, Media and ... Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, ... 2019", published by MarketsandMarkets, analyzes and studies the ... Browse 114 market data tables and ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... Dec. 7 Access Pharmaceuticals, Inc.,(OTC Bulletin ... demonstrated the,ability, using the company,s proprietary Cobalamin(TM) ... animal model of diabetes, through,its oral insulin ... based upon the body,s natural absorption of ...
... DENVER, Dec. 6 Some 5,000 COPD patients ... Antitrypsin Deficiency (Alpha-1) in,a study marking a major ... Association for Respiratory Care (AARC)., The principal ... the,Division of Pulmonary Medicine, National Jewish Medical and ...
Cached Medicine Technology:Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 2Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 3Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
... BTF-111 miniature arrayed detector ... spectrometer for ?uorescence applications ... excitation light source modules ... 2D ?uorescence measurement which ...
Inquire...
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
Medicine Products: